Experimental Diabetes Drug

By Health Day – Re-Blogged From Newsmax Health

An experimental drug may help people with type 2 diabetes curb their blood sugar without causing it to drop to dangerously low levels.

Researchers found that the compound — dubbed TTP399 for now — improved patients’ blood sugar control when it was added to the standard medication metformin for six months. And it did so without causing hypoglycemia — blood sugar drops that, if severe, can lead to convulsions or loss of consciousness.

The findings, published Jan. 16 in the journal Science Translational Medicine, come from an earlier Phase 2 trial. And more research is needed before TTP399 can be added to existing armaments against type 2 diabetes, said senior researcher Carmen Valcarce.

Continue reading